Novolin 70/30 Injectable Suspension

RxCUI: 213442
RxNorm name: Novolin 70/30 Injectable Suspension
Display name: Novolin 70/30 Injectable Suspension
Full name: Novolin 70/30 Injectable Suspension
Term type: SY
Status: DailyMed mapping
Updated: 2026-06-04 23:38:58

Purple Book Biologic Products#

BLA, Proprietary name, Proper name table
BLA	Proprietary name	Proper name	License type	Status	Latest source
019991	Novolin 70/30	insulin isophane human and insulin human	351(a)	OTC	2026-07-01

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 2 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Novolin 70/30	HUMAN INSULIN	A-S Medication Solutions	e825d7e9-467c-4f50-a6d6-f2602449c1de	2023-02-06	Warnings, Adverse reactions	Exact identifier rxcui: 213442
Novolin 70/30	HUMAN INSULIN	Novo Nordisk	508a2763-3cb7-4be5-9e53-544e84cd9b1f	2022-11-23	Warnings, Adverse reactions	Exact identifier rxcui: 213442

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 4 matching rows.

Set ID, RxNorm mappings, Terms table
Set ID	RxNorm mappings	Terms	SPL version	Label	Effective
508a2763-3cb7-4be5-9e53-544e84cd9b1f	NovoLIN 70/30 Injectable Suspension [PSN] · insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Novolin] [SBD] · Novolin 70/30 Injectable Suspension [SY] · Relion Novolin 70/30 Injectable Suspension [SY]	4	18	These highlights do not include all the information needed to use NOVOLIN 70/30 safely and effectively. See full prescribing information for NOVOLIN 70/30. NOVOLIN ® 70/30 (insulin isophane human and insulin human) injectable suspension, for subcutaneous use Initial U.S. Approval: 1991	20221123
e825d7e9-467c-4f50-a6d6-f2602449c1de	NovoLIN 70/30 Injectable Suspension [PSN] · insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Novolin] [SBD] · Novolin 70/30 Injectable Suspension [SY] · Relion Novolin 70/30 Injectable Suspension [SY]	4	14	These highlights do not include all the information needed to use NOVOLIN 70/30 safely and effectively. See full prescribing information for NOVOLIN 70/30. NOVOLIN ® 70/30 (insulin isophane human and insulin human) injectable suspension, for subcutaneous use Initial U.S. Approval: 1991	20230206
0cc57309-01ef-4a02-8d27-b981c768135a	NovoLIN 70/30 Injectable Suspension [PSN] · insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Novolin] [SBD] · Novolin 70/30 Injectable Suspension [SY] · Relion Novolin 70/30 Injectable Suspension [SY]	4	2	Novolin 70/30, 70% NPH, Human Insulin Isophane Suspension and 30% Regular, Human Insulin Injection (recombinant DNA origin) ®	20130830
8c7038f4-60d4-4604-814d-74921cdc1ad8	NovoLIN 70/30 Injectable Suspension [PSN] · insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Novolin] [SBD] · Novolin 70/30 Injectable Suspension [SY] · Relion Novolin 70/30 Injectable Suspension [SY]	4	2	Novolin ® 70/30, 70% NPH, Human Insulin Isophane Suspension and 30% Regular, Human Insulin Injection (recombinant DNA origin)	20120111